List of Excipients in API betamethasone dipropionate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing betamethasone dipropionate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme Corp | DIPROLENE AF | betamethasone dipropionate | 0085-0517 | CARBOMER HOMOPOLYMER TYPE C | |
| Merck Sharp & Dohme Corp | DIPROLENE AF | betamethasone dipropionate | 0085-0517 | CETEARETH-30 | |
| Merck Sharp & Dohme Corp | DIPROLENE AF | betamethasone dipropionate | 0085-0517 | CHLOROCRESOL | |
| Merck Sharp & Dohme Corp | DIPROLENE AF | betamethasone dipropionate | 0085-0517 | CYCLOMETHICONE | |
| Merck Sharp & Dohme Corp | DIPROLENE AF | betamethasone dipropionate | 0085-0517 | GLYCERYL OLEATE | |
| Merck Sharp & Dohme Corp | DIPROLENE AF | betamethasone dipropionate | 0085-0517 | PETROLATUM | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing betamethasone dipropionate
Detailed excipient profiles for betamethasone dipropionate
Excipient focus: BUTYLATED HYDROXYTOLUENE
betamethasone dipropionate drug variants containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | betamethasone dipropionate | 51672-1390 |
| Primus Pharmaceuticals Inc | betamethasone dipropionate | 68040-714 |
| Encore Dermatology Inc | betamethasone dipropionate | 69482-800 |
| >Company | >Ingredient | >NDC |
betamethasone dipropionate drug variants not containing BUTYLATED HYDROXYTOLUENE
Excipient focus: CARBOMER HOMOPOLYMER TYPE B
betamethasone dipropionate drug variants containing CARBOMER HOMOPOLYMER TYPE B
betamethasone dipropionate drug variants not containing CARBOMER HOMOPOLYMER TYPE B
Excipient focus: CARBOMER HOMOPOLYMER TYPE C
betamethasone dipropionate drug variants containing CARBOMER HOMOPOLYMER TYPE C
betamethasone dipropionate drug variants not containing CARBOMER HOMOPOLYMER TYPE C
Excipient focus: CETEARETH-30
betamethasone dipropionate drug variants containing CETEARETH-30
betamethasone dipropionate drug variants not containing CETEARETH-30
Excipient focus: CETETH-20
betamethasone dipropionate drug variants containing CETETH-20
betamethasone dipropionate drug variants not containing CETETH-20
Excipient focus: CETOSTEARYL ALCOHOL
betamethasone dipropionate drug variants containing CETOSTEARYL ALCOHOL
betamethasone dipropionate drug variants not containing CETOSTEARYL ALCOHOL
Excipient focus: CETYL ALCOHOL
betamethasone dipropionate drug variants containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | betamethasone dipropionate | 0713-0659 |
| Cosette Pharmaceuticals Inc | betamethasone dipropionate | 0713-0759 |
| A-S Medication Solutions | betamethasone dipropionate | 50090-5260 |
| >Company | >Ingredient | >NDC |
betamethasone dipropionate drug variants not containing CETYL ALCOHOL
Excipient focus: CHLOROCRESOL
betamethasone dipropionate drug variants containing CHLOROCRESOL
betamethasone dipropionate drug variants not containing CHLOROCRESOL
Excipient focus: CYCLOMETHICONE
betamethasone dipropionate drug variants containing CYCLOMETHICONE
betamethasone dipropionate drug variants not containing CYCLOMETHICONE
Excipient focus: CYCLOMETHICONE 5
betamethasone dipropionate drug variants containing CYCLOMETHICONE 5
betamethasone dipropionate drug variants not containing CYCLOMETHICONE 5
Excipient focus: DIAZOLIDINYL UREA
betamethasone dipropionate drug variants containing DIAZOLIDINYL UREA
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | betamethasone dipropionate | 51672-1390 |
| >Company | >Ingredient | >NDC |
betamethasone dipropionate drug variants not containing DIAZOLIDINYL UREA
Excipient focus: GLYCERYL OLEATE
betamethasone dipropionate drug variants containing GLYCERYL OLEATE
betamethasone dipropionate drug variants not containing GLYCERYL OLEATE
Excipient focus: HYDROXYETHYL CELLULOSE
betamethasone dipropionate drug variants containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | betamethasone dipropionate | 51672-1390 |
| Primus Pharmaceuticals Inc | betamethasone dipropionate | 68040-714 |
| Encore Dermatology Inc | betamethasone dipropionate | 69482-800 |
| >Company | >Ingredient | >NDC |
betamethasone dipropionate drug variants not containing HYDROXYETHYL CELLULOSE
Excipient focus: HYDROXYPROPYL CELLULOSE
betamethasone dipropionate drug variants containing HYDROXYPROPYL CELLULOSE
betamethasone dipropionate drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: ISOPROPYL ALCOHOL
betamethasone dipropionate drug variants containing ISOPROPYL ALCOHOL
betamethasone dipropionate drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: METHYLPARABEN
betamethasone dipropionate drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | betamethasone dipropionate | 51672-1390 |
| Primus Pharmaceuticals Inc | betamethasone dipropionate | 68040-714 |
| Encore Dermatology Inc | betamethasone dipropionate | 69482-800 |
| >Company | >Ingredient | >NDC |
betamethasone dipropionate drug variants not containing METHYLPARABEN
Excipient focus: MINERAL OIL
betamethasone dipropionate drug variants containing MINERAL OIL
betamethasone dipropionate drug variants not containing MINERAL OIL
Excipient focus: OLEYL ALCOHOL
betamethasone dipropionate drug variants containing OLEYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | betamethasone dipropionate | 51672-1390 |
| Primus Pharmaceuticals Inc | betamethasone dipropionate | 68040-714 |
| Encore Dermatology Inc | betamethasone dipropionate | 69482-800 |
| >Company | >Ingredient | >NDC |
betamethasone dipropionate drug variants not containing OLEYL ALCOHOL
Excipient focus: PETROLATUM
betamethasone dipropionate drug variants containing PETROLATUM
betamethasone dipropionate drug variants not containing PETROLATUM
Excipient focus: PHOSPHORIC ACID
betamethasone dipropionate drug variants containing PHOSPHORIC ACID
betamethasone dipropionate drug variants not containing PHOSPHORIC ACID
Excipient focus: POLYETHYLENE GLYCOL 1000
betamethasone dipropionate drug variants containing POLYETHYLENE GLYCOL 1000
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | betamethasone dipropionate | 0472-0380 |
| A-S Medication Solutions | betamethasone dipropionate | 50090-1839 |
| A-S Medication Solutions | betamethasone dipropionate | 50090-2182 |
| REMEDYREPACK INC | betamethasone dipropionate | 70518-3884 |
| >Company | >Ingredient | >NDC |
betamethasone dipropionate drug variants not containing POLYETHYLENE GLYCOL 1000
Excipient focus: POLYOXYL 20 CETOSTEARYL ETHER
betamethasone dipropionate drug variants containing POLYOXYL 20 CETOSTEARYL ETHER
betamethasone dipropionate drug variants not containing POLYOXYL 20 CETOSTEARYL ETHER
Excipient focus: PROPYLENE GLYCOL
betamethasone dipropionate drug variants containing PROPYLENE GLYCOL
betamethasone dipropionate drug variants not containing PROPYLENE GLYCOL
Excipient focus: PROPYLENE GLYCOL MONOPALMITOSTEARATE
betamethasone dipropionate drug variants containing PROPYLENE GLYCOL MONOPALMITOSTEARATE
betamethasone dipropionate drug variants not containing PROPYLENE GLYCOL MONOPALMITOSTEARATE
Excipient focus: PROPYLENE GLYCOL MONOSTEARATE
betamethasone dipropionate drug variants containing PROPYLENE GLYCOL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0268 |
| Taro Pharmaceuticals USA Inc | betamethasone dipropionate | 51672-1317 |
| Preferred Pharmaceuticals Inc | betamethasone dipropionate | 68788-0382 |
| >Company | >Ingredient | >NDC |
betamethasone dipropionate drug variants not containing PROPYLENE GLYCOL MONOSTEARATE
Excipient focus: PROPYLENE GLYCOL STEARATE
betamethasone dipropionate drug variants containing PROPYLENE GLYCOL STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | betamethasone dipropionate | 0472-0382 |
| >Company | >Ingredient | >NDC |
betamethasone dipropionate drug variants not containing PROPYLENE GLYCOL STEARATE
Excipient focus: PROPYLPARABEN
betamethasone dipropionate drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | betamethasone dipropionate | 51672-1390 |
| Primus Pharmaceuticals Inc | betamethasone dipropionate | 68040-714 |
| Encore Dermatology Inc | betamethasone dipropionate | 69482-800 |
| >Company | >Ingredient | >NDC |
betamethasone dipropionate drug variants not containing PROPYLPARABEN
Excipient focus: SODIUM HYDROXIDE
betamethasone dipropionate drug variants containing SODIUM HYDROXIDE
betamethasone dipropionate drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM PHOSPHATE, MONOBASIC
betamethasone dipropionate drug variants containing SODIUM PHOSPHATE, MONOBASIC
betamethasone dipropionate drug variants not containing SODIUM PHOSPHATE, MONOBASIC
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
betamethasone dipropionate drug variants containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
betamethasone dipropionate drug variants not containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
Excipient focus: SORBITAN MONOSTEARATE
betamethasone dipropionate drug variants containing SORBITAN MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | betamethasone dipropionate | 51672-1390 |
| Primus Pharmaceuticals Inc | betamethasone dipropionate | 68040-714 |
| Encore Dermatology Inc | betamethasone dipropionate | 69482-800 |
| >Company | >Ingredient | >NDC |
betamethasone dipropionate drug variants not containing SORBITAN MONOSTEARATE
Excipient focus: SORBITOL
betamethasone dipropionate drug variants containing SORBITOL
betamethasone dipropionate drug variants not containing SORBITOL
Excipient focus: STEARYL ALCOHOL
betamethasone dipropionate drug variants containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | betamethasone dipropionate | 0713-0659 |
| Cosette Pharmaceuticals Inc | betamethasone dipropionate | 0713-0759 |
| A-S Medication Solutions | betamethasone dipropionate | 50090-5260 |
| >Company | >Ingredient | >NDC |
betamethasone dipropionate drug variants not containing STEARYL ALCOHOL
Excipient focus: WATER
betamethasone dipropionate drug variants containing WATER
betamethasone dipropionate drug variants not containing WATER
Excipient focus: WHITE PETROLATUM
betamethasone dipropionate drug variants containing WHITE PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | betamethasone dipropionate | 59651-699 |
| >Company | >Ingredient | >NDC |
betamethasone dipropionate drug variants not containing WHITE PETROLATUM
Excipient focus: WHITE WAX
betamethasone dipropionate drug variants containing WHITE WAX
betamethasone dipropionate drug variants not containing WHITE WAX
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
